Factors Involved in the Apoptotic Cell Death Mechanism in Yellow Fever Hepatitis.


Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
01 06 2022
Historique:
received: 26 03 2022
revised: 05 05 2022
accepted: 22 05 2022
entrez: 24 6 2022
pubmed: 25 6 2022
medline: 28 6 2022
Statut: epublish

Résumé

Yellow fever (YF), a non-contagious infectious disease, is endemic or enzootic to the tropical regions of the Americas and Africa. Periodic outbreaks or epidemics have a significant impact on public health. Programmed cell death, or apoptosis, is generally characterised by distinct morphological changes and energy-dependent biochemical pathways. In this study, we performed immunohistochemistry analysis to identify and quantify proteases and protein targets involved in the cascade that triggers apoptosis in YF virus (YFV)-infected human hepatocytes. Liver tissue samples were collected from 26 individuals, among whom 21 were diagnosed as YF-positive, and five were flavivirus-negative and died due to other causes. The histopathological alterations in YFV-positive cases were characterised by the presence of apoptotic bodies, steatosis, cellular swelling, and extensive necrosis and haemorrhage in the hepatic lobules. Additionally, we observed an abundance of inflammatory infiltrates in the portal tract. The expression of various apoptotic markers in the hepatic parenchyma, including CASPASE 3, CASPASE 8, BAX, FAS, FASL, GRANZYME B, and SURVIVIN, differed between YFV-positive cases and controls. Collectively, this study confirmed the complexity of YFV infection-induced apoptosis in situ. However, our data suggest that apoptosis in liver parenchyma lesions may significantly contribute to the pathogenesis of fatal YF in humans.

Identifiants

pubmed: 35746675
pii: v14061204
doi: 10.3390/v14061204
pmc: PMC9227230
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Gastroenterology. 2008 May;134(6):1641-54
pubmed: 18471544
Sci Rep. 2018 Jan 8;8(1):1
pubmed: 29311619
Infect Drug Resist. 2019 Sep 13;12:2917-2921
pubmed: 31571944
Mol Cell Proteomics. 2017 Apr;16(4 suppl 1):S75-S91
pubmed: 28077444
Emerg Microbes Infect. 2018 Oct 10;7(1):167
pubmed: 30301880
Mem Inst Oswaldo Cruz. 2020 Nov 09;115:e190501
pubmed: 33174908
Microbes Infect. 2006 May;8(6):1530-8
pubmed: 16697681
Curr Opin Physiol. 2018 Jun;3:82-93
pubmed: 30320242
Med Hypotheses. 2006;67(3):618-21
pubmed: 16650626
BMC Infect Dis. 2021 Aug 16;21(1):819
pubmed: 34399718
J Gen Virol. 2016 May;97(5):1033-1036
pubmed: 26872460
Virus Res. 2006 Mar;116(1-2):91-7
pubmed: 16219382
Nat Rev Gastroenterol Hepatol. 2021 Mar;18(3):151-166
pubmed: 33128017
J Virol. 2001 Aug;75(15):6999-7008
pubmed: 11435580
Compr Physiol. 2013 Apr;3(2):977-1010
pubmed: 23720337
PLoS One. 2012;7(9):e46292
pubmed: 23050007
Emerg Infect Dis. 2004 Sep;10(9):1578-84
pubmed: 15498159
Appl Immunohistochem Mol Morphol. 2008 Mar;16(2):113-20
pubmed: 18227733
Rev Med Virol. 2013 Sep;23(5):305-18
pubmed: 23873723
Viral Immunol. 2017 Jan/Feb;30(1):13-19
pubmed: 27860556
Sci Rep. 2017 Jul 7;7(1):4848
pubmed: 28687779
Virology. 2006 Feb 5;345(1):22-30
pubmed: 16278000
Int J Mol Sci. 2020 Dec 18;21(24):
pubmed: 33353156
J Virol. 2019 Aug 13;93(17):
pubmed: 31189710
Physiol Rev. 2010 Jul;90(3):1165-94
pubmed: 20664081
Immunology. 2020 May;160(1):3-9
pubmed: 31778581
J Clin Virol. 2015 Mar;64:160-73
pubmed: 25453327
PLoS Pathog. 2008 May 30;4(5):e1000018
pubmed: 18516228
Front Microbiol. 2021 Mar 24;12:654494
pubmed: 33841381
Vet Pathol. 2004 Nov;41(6):599-607
pubmed: 15557069
Nat Neurosci. 2019 Aug;22(8):1276-1288
pubmed: 31235930
Viruses. 2017 Aug 28;9(9):
pubmed: 28846635
World J Biol Chem. 2014 May 26;5(2):93-105
pubmed: 24921001
Arch Virol. 2019 Apr;164(4):1187-1192
pubmed: 30725182
Arq Bras Cardiol. 2018 Mar;110(3):207-210
pubmed: 29694557

Auteurs

Jeferson da Costa Lopes (J)

Evandro Chagas Institut, Ministry of Health, Ananindeua 67015-120, Brazil.

Luiz Fábio Magno Falcão (LFM)

Department of Pathology, State University of Para, Belem 66050-540, Brazil.

Arnaldo Jorge Martins Filho (AJ)

Evandro Chagas Institut, Ministry of Health, Ananindeua 67015-120, Brazil.

Marcos Luiz Gaia Carvalho (MLG)

Evandro Chagas Institut, Ministry of Health, Ananindeua 67015-120, Brazil.

Caio Cesar Henriques Mendes (CCH)

Department of Pathology, State University of Para, Belem 66050-540, Brazil.

Fábio Alves Olímpio (FA)

Tripical Medicine Unit, Federal University of Para, Belem 66075-110, Brazil.

Vanessa do Socorro Cabral Miranda (V)

Evandro Chagas Institut, Ministry of Health, Ananindeua 67015-120, Brazil.

Lais Carneiro Dos Santos (LC)

Evandro Chagas Institut, Ministry of Health, Ananindeua 67015-120, Brazil.

Jannifer Oliveira Chiang (JO)

Evandro Chagas Institut, Ministry of Health, Ananindeua 67015-120, Brazil.

Ana Cecilia Ribeiro Cruz (ACR)

Evandro Chagas Institut, Ministry of Health, Ananindeua 67015-120, Brazil.

Vanessa Costa Alves Galúcio (VCA)

Department of Pathology, State University of Para, Belem 66050-540, Brazil.

Raimunda do Socorro da Silva Azevedo (R)

Evandro Chagas Institut, Ministry of Health, Ananindeua 67015-120, Brazil.

Lívia Caricio Martins (LC)

Evandro Chagas Institut, Ministry of Health, Ananindeua 67015-120, Brazil.

Maria Irma Seixas Duarte (MIS)

Schhol of Medicine, Sao Paulo University, Sao Paulo 05508-070, Brazil.

Jorge Rodrigues de Sousa (JR)

Evandro Chagas Institut, Ministry of Health, Ananindeua 67015-120, Brazil.
Department of Pathology, State University of Para, Belem 66050-540, Brazil.

Pedro Fernando da Costa Vasconcelos (PF)

Evandro Chagas Institut, Ministry of Health, Ananindeua 67015-120, Brazil.
Department of Pathology, State University of Para, Belem 66050-540, Brazil.

Juarez Antônio Simões Quaresma (JAS)

Department of Pathology, State University of Para, Belem 66050-540, Brazil.
Tripical Medicine Unit, Federal University of Para, Belem 66075-110, Brazil.
Schhol of Medicine, Sao Paulo University, Sao Paulo 05508-070, Brazil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH